SCHEMBL6557775

SCHEMBL6557775

CCC(N)C(=O)CN[S+]([O-])c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 5/20 0.40
▸ NPY5R Q15761 1/20 0.40
▸ TARS1 P26639 1/20 0.39
▸ HPGD P15428 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ CRHBP P24387 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ CRHR2 Q13324 1/20 0.39
▸ ERCC5 P28715 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ MMP1 P03956 2/20 0.36
▸ MMP2 P08253 2/20 0.36
▸ MMP13 P45452 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ ADAMTS4 O75173 1/20 0.36
▸ MMP14 P50281 1/20 0.36
▸ MEP1B Q16820 1/20 0.36
▸ ADAMTS5 Q9UNA0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5445424 0.77 MMP2 (0.61) TARS1MMP1MMP2MMP13ALDH1A1
Diphenylether SCHEMBL28267534 0.65 LTA4H (0.52) LTA4HNPY5R
Hydrochloric Acid SCHEMBL27454190 0.65 NPY5R (0.44) LTA4HNPY5RHPGDNPC1CRHBP
SCHEMBL11642407 0.64 MITF (0.57) NPY5RHPGDRAB9AALDH1A1
SCHEMBL16351385 0.63 ATM (0.49) HPGDALDH1A1
SCHEMBL16351387 0.63 ATM (0.49) HPGDALDH1A1
Diphenylether SCHEMBL7033901 0.63 LTA4H (0.60) LTA4HHPGDNPC1CRHBPRAB9A
SCHEMBL10056865 0.63 FFAR1 (0.56) LTA4HNPY5RPPARGPPARA
SCHEMBL12379268 0.63 FFAR1 (0.56) LTA4HNPY5RPPARGPPARA
SCHEMBL2292317 0.62 ACACB (0.53) LTA4HNPY5RPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1436255-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2004-07-14 — — EP disclosed
WO-2003024924-A1 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2003-03-27 — — WO disclosed
Send feedback